Cargando…

Incidence and Mortality of Prostate Cancer in Canada during 1992–2010

In Canada, prostate cancer is the most common reportable malignancy in men. We assessed the temporal trends of prostate cancer to gain insight into the geographic incidence and mortality trends of this disease. Three independent population-based cancer registries were used to retrospectively analyze...

Descripción completa

Detalles Bibliográficos
Autores principales: Lagacé, François, Ghazawi, Feras M., Le, Michelle, Savin, Evgeny, Zubarev, Andrei, Powell, Mathieu, Moreau, Linda, Sasseville, Denis, Popa, Ioana, Litvinov, Ivan V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985768/
https://www.ncbi.nlm.nih.gov/pubmed/33617514
http://dx.doi.org/10.3390/curroncol28010096
_version_ 1783668318150852608
author Lagacé, François
Ghazawi, Feras M.
Le, Michelle
Savin, Evgeny
Zubarev, Andrei
Powell, Mathieu
Moreau, Linda
Sasseville, Denis
Popa, Ioana
Litvinov, Ivan V.
author_facet Lagacé, François
Ghazawi, Feras M.
Le, Michelle
Savin, Evgeny
Zubarev, Andrei
Powell, Mathieu
Moreau, Linda
Sasseville, Denis
Popa, Ioana
Litvinov, Ivan V.
author_sort Lagacé, François
collection PubMed
description In Canada, prostate cancer is the most common reportable malignancy in men. We assessed the temporal trends of prostate cancer to gain insight into the geographic incidence and mortality trends of this disease. Three independent population-based cancer registries were used to retrospectively analyze demographic data on Canadian men diagnosed with prostate cancer and men who died of prostate cancer between the years of 1992 and 2010. The incidence and mortality rates were calculated at the provincial, city, and forward sortation area (FSA) postal code levels by using population counts that were obtained from the Canadian Census of Population. The Canadian average incidence rate was 113.57 cases per 100,000 males. There has been an overall increasing trend in crude prostate cancer incidence between 1992 and 2010 with three peaks, in 1993, 2001, and 2007. However, age-adjusted incidence rates showed no significant increase over time. The national mortality rate was calculated to be 24.13 deaths per 100,000 males per year. A decrease was noted in crude and age-adjusted mortality rates between 1992 and 2010. Several provinces, cities, and FSAs had higher incidence/mortality rates than the national average. Several of the FSA postal codes with the highest incidence/mortality rates were adjacent to one another. Several Canadian regions of high incidence for prostate cancer have been identified through this study and temporal trends are consistent with those reported in the literature. These results will serve as a foundation for future studies that will seek to identify new regional risk factors and etiologic agents.
format Online
Article
Text
id pubmed-7985768
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79857682021-03-24 Incidence and Mortality of Prostate Cancer in Canada during 1992–2010 Lagacé, François Ghazawi, Feras M. Le, Michelle Savin, Evgeny Zubarev, Andrei Powell, Mathieu Moreau, Linda Sasseville, Denis Popa, Ioana Litvinov, Ivan V. Curr Oncol Article In Canada, prostate cancer is the most common reportable malignancy in men. We assessed the temporal trends of prostate cancer to gain insight into the geographic incidence and mortality trends of this disease. Three independent population-based cancer registries were used to retrospectively analyze demographic data on Canadian men diagnosed with prostate cancer and men who died of prostate cancer between the years of 1992 and 2010. The incidence and mortality rates were calculated at the provincial, city, and forward sortation area (FSA) postal code levels by using population counts that were obtained from the Canadian Census of Population. The Canadian average incidence rate was 113.57 cases per 100,000 males. There has been an overall increasing trend in crude prostate cancer incidence between 1992 and 2010 with three peaks, in 1993, 2001, and 2007. However, age-adjusted incidence rates showed no significant increase over time. The national mortality rate was calculated to be 24.13 deaths per 100,000 males per year. A decrease was noted in crude and age-adjusted mortality rates between 1992 and 2010. Several provinces, cities, and FSAs had higher incidence/mortality rates than the national average. Several of the FSA postal codes with the highest incidence/mortality rates were adjacent to one another. Several Canadian regions of high incidence for prostate cancer have been identified through this study and temporal trends are consistent with those reported in the literature. These results will serve as a foundation for future studies that will seek to identify new regional risk factors and etiologic agents. MDPI 2021-02-21 /pmc/articles/PMC7985768/ /pubmed/33617514 http://dx.doi.org/10.3390/curroncol28010096 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lagacé, François
Ghazawi, Feras M.
Le, Michelle
Savin, Evgeny
Zubarev, Andrei
Powell, Mathieu
Moreau, Linda
Sasseville, Denis
Popa, Ioana
Litvinov, Ivan V.
Incidence and Mortality of Prostate Cancer in Canada during 1992–2010
title Incidence and Mortality of Prostate Cancer in Canada during 1992–2010
title_full Incidence and Mortality of Prostate Cancer in Canada during 1992–2010
title_fullStr Incidence and Mortality of Prostate Cancer in Canada during 1992–2010
title_full_unstemmed Incidence and Mortality of Prostate Cancer in Canada during 1992–2010
title_short Incidence and Mortality of Prostate Cancer in Canada during 1992–2010
title_sort incidence and mortality of prostate cancer in canada during 1992–2010
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985768/
https://www.ncbi.nlm.nih.gov/pubmed/33617514
http://dx.doi.org/10.3390/curroncol28010096
work_keys_str_mv AT lagacefrancois incidenceandmortalityofprostatecancerincanadaduring19922010
AT ghazawiferasm incidenceandmortalityofprostatecancerincanadaduring19922010
AT lemichelle incidenceandmortalityofprostatecancerincanadaduring19922010
AT savinevgeny incidenceandmortalityofprostatecancerincanadaduring19922010
AT zubarevandrei incidenceandmortalityofprostatecancerincanadaduring19922010
AT powellmathieu incidenceandmortalityofprostatecancerincanadaduring19922010
AT moreaulinda incidenceandmortalityofprostatecancerincanadaduring19922010
AT sassevilledenis incidenceandmortalityofprostatecancerincanadaduring19922010
AT popaioana incidenceandmortalityofprostatecancerincanadaduring19922010
AT litvinovivanv incidenceandmortalityofprostatecancerincanadaduring19922010